GSEA result further suggested that NFE2L3 may influence the ccRCC progression by regulating immune activity such as antigen processing and presentation, NOD-like receptor signaling pathway, TOLL-like receptor signaling pathway, regulation of lymphocyte-mediated immunity, adaptive immune response, et al (Figure 5C). The gene discussed is NFE2L3; the disease is nonpapillary renal cell carcinoma.